{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T05:43:56Z","timestamp":1794635036315,"version":"4.9.1"},"reference-count":146,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T00:00:00Z","timestamp":1744675200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Vitiligo is a chronic autoimmune condition characterized by the destruction of melanocytes, leading to patchy loss of skin depigmentation. Although its precise cause remains unclear, recent evidence suggests that metabolic disturbances, particularly oxidative stress and mitochondrial dysfunction, may play a significant role in the pathogenesis of the disease. Oxidative stress is thought to damage melanocytes and trigger inflammatory responses, culminating in melanocyte immune-mediate destruction. Additionally, patients with vitiligo often exhibit extra-cutaneous metabolic abnormalities such as abnormal glucose metabolism, dyslipidemia, high fasting plasma glucose levels, high blood pressure, out of range C-peptide and low biological antioxidant capacity, suggesting a potential link between metabolic impairment and vitiligo development. This implies that the loss of functional melanocytes mirrors a more general systemic targetable dysfunction. Notably, therapies targeting metabolic pathways, particularly those involving mitochondrial metabolism, such as the peroxisome proliferator-activated nuclear receptor \u03b3 (PPAR\u03b3) agonists, are currently being investigated as potential treatments for vitiligo. PPAR\u03b3 activation restores mitochondrial membrane potential, mitochondrial DNA copy number and, consequently, ATP production. Moreover, PPAR\u03b3 agonists counteract oxidative stress, reduce inflammation, inhibit apoptosis, and maintain fatty acid metabolism, in addition to the well-known capability to enhance insulin sensitivity. Additionally, increasing evidence of a strong relationship between metabolic alterations and vitiligo pathogenesis suggests a role for other approved anti-diabetic treatments, like metformin and fibrates, in vitiligo treatment. Taken together, these data support the use of approaches alternative to traditional immune-suppressive treatments for the treatment of vitiligo.<\/jats:p>","DOI":"10.3389\/fphar.2025.1546836","type":"journal-article","created":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T05:20:12Z","timestamp":1744694412000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Metabolic anomalies in vitiligo: a new frontier for drug repurposing strategies"],"prefix":"10.3389","volume":"16","author":[{"given":"Alessia","family":"Paganelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Papaccio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Picardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Bellei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,4,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s40001-024-01700-2","article-title":"Role of fenofibrate in multiple sclerosis","volume":"29","author":"Abulaban","year":"2024","journal-title":"Eur. J. Med. Res."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1038\/jid.2014.529","article-title":"Simvastatin prevents and reverses depigmentation in a mouse model of vitiligo","volume":"135","author":"Agarwal","year":"2015","journal-title":"J. Invest Dermatol Apr"},{"key":"B3","doi-asserted-by":"publisher","first-page":"132","DOI":"10.3126\/kumj.v12i2.13660","article-title":"Comparison of oxidant-antioxidant status in patients with vitiligo and healthy population","volume":"12","author":"Agrawal","year":"2015","journal-title":"Kathmandu Univ. Med. J."},{"key":"B4","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/nm.3159","article-title":"PPAR\u03b3 signaling and metabolism: the good, the bad and the future","volume":"19","author":"Ahmadian","year":"2013","journal-title":"Nat. Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1016\/j.jid.2019.12.035","article-title":"ATP-P2X7-Induced inflammasome activation contributes to melanocyte death and CD8+ T-cell trafficking to the skin in vitiligo","volume":"140","author":"Ahn","year":"2020","journal-title":"J. Invest Dermatol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1053\/j.ackd.2019.08.004","article-title":"Toxicity of metformin and hypoglycemic therapies","volume":"27","author":"Akhter","year":"2020","journal-title":"Adv. Chronic Kidney Dis."},{"key":"B7","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.jaad.2010.11.061","article-title":"Vitiligo: a comprehensive overview Part I. Introduction, epidemiology, quality of life, diagnosis, differential diagnosis, associations, histopathology, etiology, and work-up","volume":"65","author":"Alikhan","year":"2011","journal-title":"J. Am. Acad. Dermatology"},{"key":"B8","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.jphotobiol.2015.04.005","article-title":"Serum levels of homocysteine, folate and vitamin B12 in patients with vitiligo before and after treatment with narrow band ultraviolet B phototherapy and in a group of controls","volume":"148","author":"Ata\u015f","year":"2015","journal-title":"J. Photochem Photobiol. B"},{"key":"B9","doi-asserted-by":"publisher","first-page":"219","DOI":"10.4274\/balkanmedj.2016.1005","article-title":"Increased risk of metabolic syndrome in patients with vitiligo","volume":"34","author":"Ata\u015f","year":"2017","journal-title":"Balk. Med. J."},{"key":"B10","first-page":"118","article-title":"Characteristics of vitiligo in lagos, Nigeria west afr J med","volume":"28","author":"Ayanlowo","year":"2009","journal-title":"West Afr. J. Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1111\/jdv.12116","article-title":"Metformin in dermatology: an overview","volume":"27","author":"Badr","year":"2013","journal-title":"Acad. Dermatol Venereol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1200\/JCO.18.01223","article-title":"Markedly reduced risk of internal malignancies in patients with vitiligo: a nationwide population-based cohort study","volume":"10","author":"Bae","year":"2019","journal-title":"J. Clin. Oncol. Apr"},{"key":"B13","doi-asserted-by":"publisher","first-page":"612","DOI":"10.4103\/idoj.idoj_966_23","article-title":"Prevalence of metabolic syndrome in vitiligo patients and its relation to vitiligo severity \u2013 a cross-sectional study","volume":"15","author":"Bathina","year":"2024","journal-title":"Indian Dermatology Online J."},{"key":"B14","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1210\/endrev\/bnad008","article-title":"Signaling pathways of the insulin-like growth factor binding proteins","volume":"15","author":"Baxter","year":"2023","journal-title":"Endocr. Rev. Sep."},{"key":"B15","doi-asserted-by":"publisher","first-page":"e59782","DOI":"10.1371\/journal.pone.0059782","article-title":"Vitiligo: a possible model of degenerative diseases","volume":"8","author":"Bellei","year":"2013","journal-title":"PLoS One"},{"key":"B16","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1111\/j.1600-0749.2007.00385.x","article-title":"Keratinocyte cultures from involved skin in vitiligo patients show an impaired in vitro behaviour","volume":"20","author":"Bondanza","year":"2007","journal-title":"Pigment. Cell Res."},{"key":"B126","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1093\/rheumatology\/keh423","article-title":"Treatment of active psoriatic arthritis with the PPARgamma ligand pioglitazone: an open-label pilot study. Rheumatology (Oxford)","author":"Bongartz","year":"2005"},{"key":"B17","first-page":"2245","article-title":"Comment on: gale EAM (2005) Spring harvest? Reflections on the rise of type 1 diabetes","volume":"48","author":"Boucher","year":"2006","journal-title":"Diabetologia"},{"key":"B18","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.diabet.2010.11.002","article-title":"Metformin and digestive disorders","volume":"37","author":"Bouchoucha","year":"2011","journal-title":"Diabetes and Metabolism"},{"key":"B19","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1210\/er.2018-00064","article-title":"Molecular actions of PPAR\u03b1 in lipid metabolism and inflammation","volume":"39","author":"Bougarne","year":"2018","journal-title":"Endocr. Rev."},{"key":"B127","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.3390\/biom10081162","article-title":"Mitochondrial pyruvate carrier function in health and disease across the lifespan","volume":"10","author":"Buchanan","year":"2020","journal-title":"Biomolecules"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1016\/j.jaad.2019.06.022","article-title":"The association between vitiligo and diabetes mellitus: a systematic review and meta-analysis","volume":"81","author":"Chang","year":"2019","journal-title":"J. Am. Acad. Dermatology"},{"key":"B21","doi-asserted-by":"publisher","first-page":"936","DOI":"10.3390\/cells12060936","article-title":"The role of oxidative stress in vitiligo: an update on its pathogenesis and therapeutic implications","volume":"12","author":"Chang","year":"2023","journal-title":"Cells Mar. 19"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1016\/j.jid.2017.01.020","article-title":"Simvastatin protects human melanocytes from H(2)O(2)-induced oxidative stress by activating Nrf2","volume":"137","author":"Chang","year":"2017","journal-title":"J. Invest Dermatol Jun"},{"key":"B23","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.3892\/mmr.2017.6271","article-title":"Protective effect of mitochondria-targeted peptide MTP-131 against oxidative stress-induced apoptosis in RGC-5 cells","volume":"15","author":"Chen","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"B24","doi-asserted-by":"publisher","first-page":"6960","DOI":"10.3390\/ijms23136960","article-title":"Metformin attenuates UVA-induced skin photoaging by suppressing mitophagy and the PI3K\/AKT\/mTOR pathway","volume":"23","author":"Chen","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"B25","doi-asserted-by":"publisher","first-page":"154338","DOI":"10.1016\/j.metabol.2020.154338","article-title":"The role of peroxisome proliferator-activated receptors (PPAR) in immune responses","volume":"114","author":"Christofides","year":"2021","journal-title":"Metabolism"},{"key":"B26","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1111\/ddg.14652","article-title":"Association between vitiligo and metabolic syndrome: a systematic review and meta\u2010analysis","volume":"20","author":"Chuang","year":"2022","journal-title":"J. Dtsch. Derma Gesell"},{"key":"B27","doi-asserted-by":"publisher","first-page":"E252","DOI":"10.1152\/ajpendo.00424.2003","article-title":"Identification of a novel mitochondrial protein (\u201cmitoNEET\u201d) cross-linked specifically by a thiazolidinedione photoprobe","volume":"286","author":"Colca","year":"2004","journal-title":"Am. J. Physiol. Endocrinol. Metab. Feb"},{"key":"B30","first-page":"1659","article-title":"HSF1-Dependent Autophagy Activation Contributes to the Survival of Melanocytes Under Oxidative Stress in Vitiligo","volume-title":"J. Invest. Dermatol.","author":"Cui","year":"2022"},{"key":"B28","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1002\/jcp.22027","article-title":"Membrane lipid defects are responsible for the generation of reactive oxygen species in peripheral blood mononuclear cells from vitiligo patients","volume":"223","author":"Dell'Anna","year":"2010","journal-title":"Cell Physiol. Apr"},{"key":"B29","doi-asserted-by":"publisher","first-page":"13663","DOI":"10.1038\/s41598-017-13961-5","article-title":"Energetic mitochondrial failing in vitiligo and possible rescue by cardiolipin","volume":"7","author":"Dell\u2019Anna","year":"2017","journal-title":"Sci. Rep."},{"key":"B31","doi-asserted-by":"publisher","first-page":"5422","DOI":"10.1073\/pnas.1303360110","article-title":"Thiazolidinediones are acute, specific inhibitors of the mitochondrial pyruvate carrier","volume":"2","author":"Divakaruni","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A. Apr"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.3390\/ijms19041222","article-title":"Mechanisms of ATP release by inflammatory cells","volume":"19","author":"Dosch","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"B33","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.biopha.2016.11.105","article-title":"Mechanism of action and effect of immune-modulating agents in the treatment of psoriasis","volume":"85","author":"El-Gharabawy","year":"2017","journal-title":"Biomed. and Pharmacother."},{"key":"B34","doi-asserted-by":"publisher","first-page":"e188","DOI":"10.1111\/ajd.13999","article-title":"Insulin-like growth factor 1: a new prime mover in the pathogenesis of vitiligo","volume":"64","author":"El-Komy","year":"2023","journal-title":"Australas. J. Dermatol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.1007\/s13555-023-01001-2","article-title":"Comorbidity burden among patients with vitiligo in the United States: a large-scale retrospective claims database analysis","volume":"13","author":"Ezzedine","year":"2023","journal-title":"Dermatol Ther. (Heidelb)"},{"key":"B36","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3389\/fpsyg.2024.1333723","article-title":"Validation of the DLQI questionnaire in assessing the disease burden and principal aspects related to life quality of vitiligo patients","volume":"30","author":"Fekete","year":"2024","journal-title":"Front. Psychol. May"},{"key":"B37","doi-asserted-by":"publisher","first-page":"106114","DOI":"10.1016\/j.phrs.2022.106114","article-title":"Mitochondria as an important target of metformin: the mechanism of action, toxic and side effects, and new therapeutic applications","volume":"177","author":"Feng","year":"","journal-title":"Pharmacol. Res."},{"key":"B38","doi-asserted-by":"publisher","first-page":"986847","DOI":"10.3389\/fimmu.2022.986847","article-title":"Glutaminolysis and CD4+ T-cell metabolism in autoimmunity: from pathogenesis to therapy prospects","volume":"13","author":"Feng","year":"","journal-title":"Front. Immunol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1016\/j.jid.2023.04.013","article-title":"Risk of melanoma and nonmelanoma skin cancer in people with vitiligo: United Kingdom population-based cohort study","volume":"143","author":"Ferguson","year":"2023","journal-title":"J. Invest Dermatol Nov."},{"key":"B124","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.1007\/s00125-005-0028-z","article-title":"Spring harvest? Reflections on the rise of type 1 diabetes","volume":"48","author":"Gale","year":"2005","journal-title":"Diabetologia"},{"key":"B125","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/j.1749-6632.2012.06513.x","article-title":"The link between altered cholesterol metabolism and Alzheimer\u2019s disease","volume":"1259","author":"Gamba","year":"2012","journal-title":"Ann. N Y Acad. Sci."},{"key":"B40","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s00403-019-01996-9","article-title":"Predominant role of innate pro-inflammatory cytokines in vitiligo disease","volume":"312","author":"Gholijani","year":"2020","journal-title":"Arch. Dermatol Res."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1007\/s12325-023-02434-z","article-title":"\u03a4he endless beauty of metformin: does it also protect from skin aging? A narrative review","volume":"40","author":"Gouveri","year":"2023","journal-title":"Adv. Ther."},{"key":"B42","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1097\/DAD.0000000000002269","article-title":"Reflectance Confocal Microscopy for Identification of Vulvar Lichen Sclerosus et Atrophicus and Vitiligo","volume":"44","author":"Gu","year":"2022","journal-title":"Am. J. Dermatopathol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"100064","DOI":"10.1016\/j.esmoop.2021.100064","article-title":"Immune checkpoint inhibitor-associated vitiligo and its impact on survival in patients with metastatic melanoma: an Italian Melanoma Intergroup study","volume":"6","author":"Guida","year":"2021","journal-title":"ESMO Open Apr"},{"key":"B128","doi-asserted-by":"publisher","first-page":"151","DOI":"10.5021\/ad.2012.24.2.151","article-title":"Induction of melanogenesis by rapamycin in human MNT-1 melanoma cells","volume":"24","author":"Hah","year":"2012","journal-title":"Ann. Dermatol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1016\/j.jid.2023.02.031","article-title":"Automated mass screening for comorbidities of vitiligo using the national health insurance database","volume":"143","author":"Han","year":"2023","journal-title":"J. Invest Dermatol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"AB198","DOI":"10.1016\/j.jaad.2020.06.881","article-title":"17755 Global survey investigating the prevalence of vitiligo and vitiligo signs among adults in Europe, Japan, and the United States","volume":"83","author":"Harris","year":"2020","journal-title":"J. Am. Acad. Dermatology"},{"key":"B46","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1111\/j.1365-4632.2004.02027.x","article-title":"A comparative study of superoxide dismutase, catalase, and glutathione peroxidase activities and nitrate levels in vitiligo patients","volume":"44","author":"Hazneci","year":"2005","journal-title":"Int. J. Dermatol."},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1072837","article-title":"Beyond skin white spots: vitiligo and associated comorbidities","volume":"23","author":"Hu","year":"2023","journal-title":"Front. Med. (Lausanne) Feb"},{"key":"B48","doi-asserted-by":"publisher","first-page":"606","DOI":"10.5114\/ada.2023.130524","article-title":"The efficacy of metformin for the treatment of psoriasis: a meta-analysis study","volume":"40","author":"Huang","year":"2023","journal-title":"pdia"},{"key":"B49","doi-asserted-by":"publisher","first-page":"e0256622","DOI":"10.1371\/journal.pone.0256622","article-title":"Melanocyte progenitor cells reside in human subcutaneous adipose tissue","volume":"25","author":"Ikeda","year":"2021","journal-title":"PLoS One Aug"},{"key":"B50","doi-asserted-by":"publisher","first-page":"110300","DOI":"10.1016\/j.clim.2024.110300","article-title":"Abnormal metabolism in melanocytes participates in the activation of dendritic cell in halo nevus","volume":"265","author":"Jiang","year":"2024","journal-title":"Clin. Immunol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1111\/ddg.14717","article-title":"Association between vitiligo and relevant components of metabolic syndrome: a systematic review and meta\u2010analysis","volume":"20","author":"Kang","year":"2022","journal-title":"J. Dtsch. Derma Gesell"},{"key":"B52","doi-asserted-by":"publisher","first-page":"541","DOI":"10.2340\/00015555-1141","article-title":"Insulin resistance is increased in patients with vitiligo","volume":"91","author":"Karadag","year":"2011","journal-title":"Acta Derm. Venerol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1089\/ars.2009.2976","article-title":"Dysfunction of glutathione S-transferase leads to excess 4-hydroxy-2-nonenal and H(2)O(2) and impaired cytokine pattern in cultured keratinocytes and blood of vitiligo patients","volume":"13","author":"Kostyuk","year":"2010","journal-title":"Antioxid. Redox Signal"},{"key":"B54","doi-asserted-by":"publisher","first-page":"eabn9299","DOI":"10.1126\/sciadv.abn9299","article-title":"Altered epidermal proliferation, differentiation, and lipid composition: novel key elements in the vitiligo puzzle","volume":"8","author":"Kovacs","year":"2022","journal-title":"M.Sci Adv"},{"key":"B55","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.jid.2017.06.033","article-title":"Vitiligo skin: exploring the dermal compartment","volume":"138","author":"Kovacs","year":"2018","journal-title":"J. Investigative Dermatology"},{"key":"B56","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s00403-022-02358-8","article-title":"Investigating the epidemiological relationship between vitiligo and psoriasis: a population-based study","volume":"315","author":"Kridin","year":"2023","journal-title":"Arch. Dermatol Res. Apr"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2024.1387404","article-title":"Clarifying the association between Parkinson's disease and vitiligo: a population-based large-scale study","volume":"21","author":"Kridin","year":"2024","journal-title":"Front. Neurol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"797","DOI":"10.3892\/etm.2021.10229","article-title":"Updates and new medical treatments for vitiligo (Review)","volume":"22","author":"Kubelis-L\u00f3pez","year":"2021","journal-title":"Exp. Ther. Med."},{"key":"B59","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1111\/j.1600-0749.2005.00242.x","article-title":"Early disease onset and increased risk of other autoimmune diseases in familial generalized vitiligo","volume":"18","author":"Laberge","year":"2005","journal-title":"Pigment. Cell Res."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1016\/j.freeradbiomed.2013.08.189","article-title":"Involvement of superoxide dismutase isoenzymes and their genetic variants in progression of and higher susceptibility to vitiligo","volume":"65","author":"Laddha","year":"2013","journal-title":"Free Radic. Biol. Med."},{"key":"B61","doi-asserted-by":"publisher","first-page":"3799","DOI":"10.1111\/bph.17309","article-title":"Off-target effects of statins: molecular mechanisms, side effects and the emerging role of kinases","volume":"181","author":"Lagunas-Rangel","year":"2024","journal-title":"Br. J. Pharmacol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1758-5996-5-1","article-title":"Apoptosis rate and transcriptional response of pancreatic islets exposed to the PPAR gamma agonist Pioglitazone","volume":"5","author":"Lamounier","year":"2013","journal-title":"Diabetol. Metab. Syndr."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1016\/j.jid.2019.02.031","article-title":"Critical role of ATP-P2X7 Axis in UV-induced melanogenesis","volume":"139","author":"Lee","year":"","journal-title":"J. Invest Dermatol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.jid.2022.10.021","article-title":"Comorbidities in patients with vitiligo: a systematic review and meta-analysis","volume":"143","author":"Lee","year":"2023","journal-title":"J. Invest Dermatol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1001\/jamadermatol.2019.0696","article-title":"Treatment outcomes of topical calcineurin inhibitor therapy for patients with vitiligo: a systematic review and meta-analysis","volume":"155","author":"Lee","year":"","journal-title":"JAMA Dermatol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"3849","DOI":"10.3390\/ijms22083849","article-title":"Cellular senescence and inflammaging in the skin microenvironment","volume":"22","author":"Lee","year":"2021","journal-title":"IJMS"},{"key":"B67","doi-asserted-by":"publisher","first-page":"2326297","DOI":"10.1080\/07853890.2024.2326297","article-title":"Risk factors for cardiovascular diseases in patients with vitiligo: an analysis of current evidence","volume":"56","author":"Liang","year":"2024","journal-title":"Ann. Med. Dec"},{"key":"B139","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1007\/s11010-022-04417-0","article-title":"Peroxisome proliferator-activator receptor gamma and psoriasis, molecular and cellular biochemistry","volume":"477","author":"Lin","year":"2022","journal-title":"Mol. Cell. Biochem."},{"key":"B68","doi-asserted-by":"publisher","first-page":"1055958","DOI":"10.3389\/fimmu.2022.1055958","article-title":"Immunometabolism in the pathogenesis of vitiligo","volume":"13","author":"Lyu","year":"2022","journal-title":"Front. Immunol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s00281-021-00885-6","article-title":"Genetic overlap between type 1 diabetes and other autoimmune diseases","volume":"44","author":"M\u00e1rquez","year":"2022","journal-title":"Semin. Immunopathol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1016\/j.jid.2021.09.015","article-title":"Vitiligo skin T cells are prone to produce type 1 and type 2 cytokines to induce melanocyte dysfunction and epidermal inflammatory response through jak signaling","volume":"142","author":"Martins","year":"2022","journal-title":"J. Invest Dermatol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1042\/BJ20141171","article-title":"Mitochondrial pyruvate transport: a historical perspective and future research directions","volume":"15","author":"McCommis","year":"2015","journal-title":"Biochem. J. Mar."},{"key":"B72","doi-asserted-by":"publisher","first-page":"7249","DOI":"10.1074\/jbc.RA119.011110","article-title":"Restoring mitochondrial superoxide levels with elamipretide (MTP-131) protects db\/db mice against progression of diabetic kidney disease","volume":"295","author":"Miyamoto","year":"2020","journal-title":"J. Biol. Chem."},{"key":"B73","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1001\/jamadermatol.2014.3324","article-title":"Association of Vitiligo and Alopecia Areata with atopic dermatitis: a systematic review and meta-analysis","volume":"151","author":"Mohan","year":"2015","journal-title":"JAMA Dermatol"},{"key":"B129","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1038\/jid.2013.165","article-title":"Autophagy has a significant role in determining skin color by regulating melanosome degradation in keratinocytes","volume":"133","author":"Murase","year":"2013","journal-title":"J. Invest. Dermatol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"493","DOI":"10.4103\/idoj.idoj_674_22","article-title":"A notorious trio! Inflammation, metabolic syndrome and vitiligo","volume":"28","author":"Mustafa","year":"2023","journal-title":"Indian Dermatol Online J. Jun"},{"key":"B75","doi-asserted-by":"publisher","first-page":"e98641","DOI":"10.1371\/journal.pone.0098641","article-title":"Insulin-like-growth-factor-binding-protein-3 (IGFBP-3) contrasts melanoma progression in vitro and in vivo","volume":"9","author":"Naspi","year":"2014","journal-title":"PLoS One"},{"key":"B130","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.3760\/cma.j.issn.0376-2491.2016.26.006","article-title":"Relationship between autophagy of melanocytes in patients with vitiligo and clinical types","volume":"96","author":"Nie","year":"2016","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"B76","doi-asserted-by":"publisher","first-page":"14612","DOI":"10.1038\/s41598-024-65722-w","article-title":"Topical application of simvastatin acid sodium salt and atorvastatin calcium salt in vitiligo patients. Results of the randomized, double-blind EVRAAS pilot study","volume":"25","author":"Niezgoda","year":"2024","journal-title":"Sci. Rep. Jun"},{"key":"B77","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1476-511X-3-7","article-title":"Positive pleiotropic effects of HMG-CoA reductase inhibitor on vitiligo","volume":"10","author":"No\u00ebl","year":"2004","journal-title":"Lipids Health Dis."},{"key":"B78","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1093\/jb\/mvz055","article-title":"Deciphering the mechanism for induction of senescence-associated secretory phenotype (SASP) and its role in ageing and cancer development","volume":"166","author":"Ohtani","year":"2019","journal-title":"J. Biochem."},{"key":"B131","doi-asserted-by":"publisher","first-page":"6817","DOI":"10.3390\/ijms22136817","article-title":"The Roles of the IGF Axis in the Regulation of the Metabolism: Interaction and Difference between Insulin Receptor Signaling and IGF-I Receptor Signaling","volume":"22","author":"Okuyama","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B79","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.1111\/j.1467-789X.2010.00773.x","article-title":"Melanin and melanogenesis in adipose tissue: possible mechanisms for abating oxidative stress and inflammation?","volume":"12","author":"Page","year":"2011","journal-title":"Obes. Rev"},{"key":"B80","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1016\/j.jaad.2014.07.050","article-title":"Markedly reduced incidence of melanoma and nonmelanoma skin cancer in a nonconcurrent cohort of 10,040 patients with vitiligo","volume":"71","author":"Paradisi","year":"2014","journal-title":"J. Am. Acad. Dermatol"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1205909","article-title":"Histopathological differences between vitiligo and lichen sclerosus et atrophicus using quantitative immunohistochemical analysis","volume":"14","author":"Park","year":"2023","journal-title":"Front. Med. (Lausanne) Jul"},{"key":"B132","doi-asserted-by":"publisher","first-page":"10201","DOI":"10.3390\/ijms251810201","article-title":"Markers of metabolic abnormalities in vitiligo patients","volume":"25","author":"Papaccio","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"B133","doi-asserted-by":"publisher","first-page":"e148","DOI":"10.1111\/j.1468-3083.2012.04504.x","article-title":"Association of halo nevus\/i and vitiligo in childhood: a retrospective observational study","volume":"27","author":"Patrizi","year":"2013","journal-title":"Eur. Acad. Dermatol. Venereol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"15011","DOI":"10.1038\/nrdp.2015.11","article-title":"Vitiligo","volume":"1","author":"Picardo","year":"2015","journal-title":"Nat. Rev. Dis. Prim."},{"key":"B83","doi-asserted-by":"publisher","first-page":"S41","DOI":"10.1111\/dth.12012","article-title":"Metabolic syndrome in vitiligo","volume":"25","author":"Pietrzak","year":"2012","journal-title":"Dermatol Ther."},{"key":"B84","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1111\/j.1600-0625.2009.00912.x","article-title":"What are melanocytes really doing all day Long","volume":"18","author":"Plonka","year":"2009","journal-title":"Exp. Dermatol"},{"key":"B134","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1042\/BCJ20210450","article-title":"The complex interplay between autophagy and cell death pathways","volume":"479","author":"Ploumi","year":"2022","journal-title":"Biochem. J."},{"key":"B85","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.3390\/cells9061384","article-title":"Effects of GH\/IGF on the aging mitochondria","volume":"9","author":"Poudel","year":"2020","journal-title":"Cells"},{"key":"B135","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1385\/cbb:32:1-3:187","article-title":"Peroxisome proliferator-activated receptors, coactivators, and downstream targets","volume":"32","author":"Qi","year":"2000","journal-title":"Cell Biochem. Biophys."},{"key":"B136","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/3401570","article-title":"Dysfunction of autophagy: a possible mechanism involved in the pathogenesis of vitiligo by breaking the redox balance of melanocytes","author":"Qiao","year":"2016","journal-title":"Oxid. Med. Cell Longev."},{"key":"B137","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/s41420-020-0266-3","article-title":"Dysfunction of ATG7-dependent autophagy dysregulates the antioxidant response and contributes to oxidative stress-induced biological impairments in human epidermal melanocytes","volume":"6","author":"Qiao","year":"2020","journal-title":"Cell Death Discov."},{"key":"B86","doi-asserted-by":"publisher","first-page":"2890","DOI":"10.1007\/s12325-024-02875-0","article-title":"Epidemiology and treatment patterns of patients with vitiligo: a real-world analysis","volume":"41","author":"Ramot","year":"2024","journal-title":"Adv. Ther"},{"key":"B87","doi-asserted-by":"publisher","first-page":"2597","DOI":"10.1007\/s00403-023-02661-y","article-title":"Association of vitiligo with multiple cutaneous and extra-cutaneous autoimmune diseases: a nationwide cross-sectional study","volume":"315","author":"Rios-Duarte","year":"2023","journal-title":"Arch. Dermatol Res. Nov."},{"key":"B88","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.jid.2023.08.012","article-title":"The risk of keratinocyte cancer in vitiligo and the potential mechanisms involved","volume":"144","author":"Rooker","year":"2024","journal-title":"J. Invest Dermatol Feb"},{"key":"B89","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1007\/s13555-024-01212-1","article-title":"Disease course, treatment patterns and goals among patients with non-segmental vitiligo across europe and the United States","volume":"14","author":"Rosmarin","year":"2024","journal-title":"Dermatol Ther. (Heidelb)"},{"key":"B138","doi-asserted-by":"crossref","first-page":"33249","DOI":"10.1038\/srep33249","article-title":"Mitochondrial dysfunction is an important cause of neurological deficits in an inflammatory model of multiple sclerosis","volume":"6","author":"Sadeghian","year":"2016","journal-title":"Sci. Rep."},{"key":"B90","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1016\/j.jid.2017.04.025","article-title":"MicroRNA-211 regulates oxidative phosphorylation and energy metabolism in human vitiligo","volume":"137","author":"Sahoo","year":"2017","journal-title":"J. Invest Dermatol"},{"key":"B140","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1038\/nature07383","article-title":"Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1b production","volume":"456","author":"Saitoh","year":"2008","journal-title":"Nature."},{"key":"B91","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1111\/j.1365-4632.2008.03660.x","article-title":"From basic research to the bedside: efficacy of topical treatment with pseudocatalase PC-KUS in 71 children with vitiligo","volume":"47","author":"Schallreuter","year":"2008","journal-title":"Int. J. Dermatol"},{"key":"B92","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1111\/j.1463-1326.2010.01262.x","article-title":"Cardiovascular risk and thiazolidinediones--what do meta-analyses really tell us?","volume":"12","author":"Schernthaner","year":"2010","journal-title":"Diabetes Obes. Metab."},{"key":"B141","doi-asserted-by":"publisher","first-page":"945","DOI":"10.2174\/1389450118666170613081730","article-title":"Metformin, a new era for an old drug in the treatment of immune mediated disease","volume":"19","author":"Schuiveling","year":"2018","journal-title":"Curr. Drug. Targets."},{"key":"B93","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1111\/pcmr.12949","article-title":"An update on Vitiligo pathogenesis","volume":"34","author":"Seneschal","year":"2021","journal-title":"Pigment. Cell Melanoma Res."},{"key":"B94","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1111\/j.1600-0749.2006.00299.x","article-title":"Antioxidant status of segmental and non\u2010segmental vitiligo","volume":"19","author":"Shajil","year":"2006","journal-title":"Pigment Cell Res."},{"key":"B95","doi-asserted-by":"publisher","first-page":"e15969","DOI":"10.1111\/dth.15969","article-title":"Simvastatin and non-segmental vitiligo: a new potential treatment option?","volume":"35","author":"Shaker","year":"2022","journal-title":"Dermatol Ther. Dec"},{"key":"B96","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1111\/exd.14317","article-title":"Integrated analysis of miRNA-mRNA networks reveals a strong anti-skin cancer signature in vitiligo epidermis","volume":"30","author":"Singh","year":"2021","journal-title":"Exp. Dermatol"},{"key":"B97","doi-asserted-by":"publisher","first-page":"5225","DOI":"10.3390\/jcm13175225","article-title":"Vitiligo: from pathogenesis to treatment","volume":"3","author":"Speeckaert","year":"2024","journal-title":"Clin. Med. Sep."},{"key":"B98","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.jid.2020.06.004","article-title":"The genetic basis of vitiligo","volume":"141","author":"Spritz","year":"2021","journal-title":"J. Invest Dermatol Feb"},{"key":"B99","doi-asserted-by":"publisher","first-page":"713","DOI":"10.36849\/JDD.2020.4874","article-title":"Oral metformin for treating dermatological diseases: a systematic review","volume":"19","author":"Sung","year":"2020","journal-title":"JDD"},{"key":"B100","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1161\/CIRCULATIONAHA.123.065298","article-title":"Novel role for cardiolipin as a target of therapy to mitigate myocardial injury caused by venoarterial extracorporeal membrane oxygenation","volume":"149","author":"Swain","year":"2024","journal-title":"Circulation"},{"key":"B101","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.abd.2019.07.006","article-title":"Higher incidence of metabolic syndrome components in vitiligo patients: a prospective cross-sectional study","volume":"95","author":"Tanacan","year":"2020","journal-title":"An. Bras. Dermatol."},{"key":"B102","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.1111\/jdv.19162","article-title":"Topical ruxolitinib: a new treatment for vitiligo","volume":"37","author":"Tavoletti","year":"2023","journal-title":"J. Eur. Acad. Dermatol Venereol."},{"key":"B103","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.jaad.2018.08.029","article-title":"Serum homocysteine, folate, and vitamin B(12) levels in patients with vitiligo and their potential roles as disease activity biomarkers: a systematic review and meta-analysis","volume":"80","author":"Tsai","year":"2019","journal-title":"Am. Acad. Dermatol Mar."},{"key":"B104","doi-asserted-by":"publisher","first-page":"108178","DOI":"10.1016\/j.exer.2020.108178","article-title":"Mitochondrial targeted therapy with elamipretide (MTP-131) as an adjunct to tumor necrosis factor inhibition for traumatic optic neuropathy in the acute setting","volume":"199","author":"Tse","year":"2020","journal-title":"Exp. Eye Res."},{"key":"B105","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1038\/s41467-019-09963-8","article-title":"Innate lymphocyte-induced CXCR3B-mediated melanocyte apoptosis is a potential initiator of T-cell autoreactivity in vitiligo","volume":"10","author":"Tulic","year":"2019","journal-title":"Nat. Commun."},{"key":"B106","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1111\/ijd.17157","article-title":"Janus kinase inhibitors and the changing landscape of vitiligo management: a scoping review","volume":"63","author":"Utama","year":"2024","journal-title":"Int. J. Dermatol"},{"key":"B145","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1111\/j.1468-3083.2011.04160.x","article-title":"Halo naevi with associated vitiligo-like depigmentations: pathogenetic hypothesis","volume":"26","author":"van Geel","year":"2012","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"B146","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1016\/j.jid.2015.12.040","article-title":"Development and validation of the vitiligo extent score (VES): an international collaborative initiative","volume":"136","author":"van Geel","year":"2016","journal-title":"J. Invest. Dermatol."},{"key":"B107","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.jaad.2016.06.015","article-title":"A double-blind, placebo-controlled, phase-II clinical trial to evaluate oral simvastatin as a treatment for vitiligo","volume":"76","author":"Vanderweil","year":"2017","journal-title":"J. Am. Acad. Dermatol Jan."},{"key":"B108","doi-asserted-by":"publisher","first-page":"000844","DOI":"10.12890\/2018_000844","article-title":"Statin-related lichenoid dermatosis: an uncommon adverse reaction to a common treatment","volume":"5","author":"Vesza","year":"2018","journal-title":"Eur. J. Case Rep. Intern Med."},{"key":"B109","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1042\/CS20080195","article-title":"PPARgamma and its ligands: therapeutic implications in cardiovascular disease","volume":"116","author":"Villacorta","year":"2009","journal-title":"Clin. Sci."},{"key":"B110","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.cell.2007.12.032","article-title":"Oncogenic BRAF induces senescence and apoptosis through pathways mediated by the secreted protein IGFBP7","volume":"132","author":"Wajapeyee","year":"2008","journal-title":"Cell Feb 8"},{"key":"B111","doi-asserted-by":"publisher","first-page":"2470","DOI":"10.1007\/s00125-005-0004-7","article-title":"Impaired beta cell glucose sensitivity and whole-body insulin sensitivity as predictors of hyperglycaemia in non-diabetic subjects","volume":"48","author":"Walker","year":"2005","journal-title":"Diabetologia"},{"key":"B142","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.2147\/CCID.S470149","article-title":"Identification of hub genes in comorbidity of psoriasis and vitiligo using bioinformatics analysis","volume":"17","author":"Wang","year":"2024","journal-title":"Clin. Cosmet. Investig. Dermatol."},{"key":"B112","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1111\/1346-8138.12725","article-title":"Differential expression analysis of miRNA in peripheral blood mononuclear cells of patients with non-segmental vitiligo","volume":"42","author":"Wang","year":"2015","journal-title":"J. Dermatol Feb"},{"key":"B113","doi-asserted-by":"publisher","first-page":"20195","DOI":"10.1038\/s41598-021-99786-9","article-title":"Reduced risk of skin cancer and internal malignancies in vitiligo patients: a retrospective population-based cohort study in Taiwan","volume":"11","author":"Weng","year":"2021","journal-title":"Sci. Rep"},{"key":"B114","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1016\/j.jid.2024.02.007","article-title":"Emerging role of fibroblasts in vitiligo: a formerly underestimated rising star","volume":"144","author":"Wu","year":"2024","journal-title":"J. Invest Dermatol. Aug"},{"key":"B147","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.3390\/cells11071116","article-title":"Identification and validation of autophagy-related genes in vitiligo","author":"Yang","year":"2022","journal-title":"Cells"},{"key":"B115","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s40257-018-0394-1","article-title":"Association between psoriasis and Vitiligo: a systematic review and meta-analysis","volume":"20","author":"Yen","year":"2019","journal-title":"Am. J. Clin. Dermatol"},{"key":"B116","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1111\/j.1346-8138.2003.tb00356.x","article-title":"The role of oxidants and antioxidants in generalized vitiligo","volume":"30","author":"Yildirim","year":"2003","journal-title":"J. Dermatology"},{"key":"B117","doi-asserted-by":"publisher","first-page":"e51040","DOI":"10.1371\/journal.pone.0051040","article-title":"Transcriptome analysis reveals markers of aberrantly activated innate immunity in vitiligo lesional and non-lesional skin","volume":"7","author":"Yu","year":"2012","journal-title":"PLoS ONE"},{"key":"B144","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1038\/jid.2014.439","article-title":"Suppression of autophagy dysregulates the antioxidant response and causes premature senescence of melanocytes","volume":"135","author":"Zhang","year":"2015","journal-title":"J. Invest. Dermatol."},{"key":"B118","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1007\/s10238-022-00904-2","article-title":"Efficacy of fibrates in the treatment of primary biliary cholangitis: a meta-analysis","volume":"23","author":"Zhang","year":"2022","journal-title":"Clin. Exp. Med."},{"key":"B119","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1136\/jim-2020-001390","article-title":"Efficacy and safety of oral simvastatin in the treatment of patients with vitiligo","volume":"69","author":"Zhang","year":"2021","journal-title":"J. Investig. Med. Feb"},{"key":"B120","doi-asserted-by":"publisher","first-page":"e0163806","DOI":"10.1371\/journal.pone.0163806","article-title":"The prevalence of vitiligo: a meta-analysis","volume":"11","author":"Zhang","year":"2016","journal-title":"PLoS One"},{"key":"B121","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.devcel.2018.04.025","article-title":"Distant insulin signaling regulates vertebrate pigmentation through the sheddase Bace2","volume":"45","author":"Zhang","year":"2018","journal-title":"Dev. Cell"},{"key":"B122","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s00403-008-0900-z","article-title":"The analysis of genetics and associated autoimmune diseases in Chinese vitiligo patients","volume":"301","author":"Zhang","year":"2009","journal-title":"Arch. Dermatol Res."},{"key":"B123","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.det.2019.08.005","article-title":"Phototherapy for vitiligo","volume":"38","author":"Zubair","year":"2020","journal-title":"Dermatol Clin."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1546836\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T05:20:14Z","timestamp":1744694414000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1546836\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,15]]},"references-count":146,"alternative-id":["10.3389\/fphar.2025.1546836"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2025.1546836","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,15]]},"article-number":"1546836"}}